AMICUS THERAPEUTICS, INC. — Director's Dealing 2014

Mar 10, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-03-07

Reporting Person: Barth Jay (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-03-07	Stock Options (right to buy)	$2.29	A	175000	Acquired	2024-03-07	Common Stock (175000)	Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on March 7, 2015. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on April 1, 2015, with the final installment vesting on March 1, 2018.